Moreover, it is notable that in the initial description of the doxycycline-inducible shFxn mouse model, it was reported that many of the disease features are reversible (17), i.e. restoring Fxn expression by halting doxycycline administration could reverse many FA pathologies, including ataxia. The gene discussed is FXN; the disease is Ataxia.